Home
>
National Drug Code (NDC)
>
Butorphanol Tartrate
Butorphanol Tartrate - 0409-1626-02 - (Butorphanol Tartrate)
Drug Information of Butorphanol Tartrate
| Product NDC: | 0409-1626 |
| Proprietary Name: | Butorphanol Tartrate |
| Non Proprietary Name: | Butorphanol Tartrate |
| Active Ingredient(s): | 2 mg/mL & nbsp; Butorphanol Tartrate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Butorphanol Tartrate
| Product NDC: | 0409-1626 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074626 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19970123 |
Package Information of Butorphanol Tartrate
| Package NDC: | 0409-1626-02 |
| Package Description: | 3 CONTAINER in 1 CASE (0409-1626-02) > 10 VIAL, SINGLE-DOSE in 1 CONTAINER > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Butorphanol Tartrate
| NDC Code | 0409-1626-02 |
| Proprietary Name | Butorphanol Tartrate |
| Package Description | 3 CONTAINER in 1 CASE (0409-1626-02) > 10 VIAL, SINGLE-DOSE in 1 CONTAINER > 2 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0409-1626 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Butorphanol Tartrate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 19970123 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | BUTORPHANOL TARTRATE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |
